Education
About Us
Working with TipRanks
Follow Us
Integral Diagnostics Ltd. (AU:IDX)
ASX:IDX
RESEARCH TOOLSreports
Total Valuation
Integral Diagnostics Ltd. has a market cap or net worth of AU$864.04M. The enterprise value is ―.
Market CapAU$864.04M
Enterprise Value―
Share Statistics
Integral Diagnostics Ltd. has 372,429,530 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding372,429,530
Owned by Insiders0.23%
Owned by Institutions―
Financial Efficiency
Integral Diagnostics Ltd.’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is 6.68%.
Return on Equity (ROE)-0.20
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)6.68%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee237.58K
Profits Per Employee-30.70K
Employee Count1,977
Asset Turnover0.63
Inventory Turnover13.88
Valuation Ratios
The current PE Ratio of Integral Diagnostics Ltd. is -9.96. Integral Diagnostics Ltd.’s PEG ratio is 1.02.
PE Ratio-9.96
PS Ratio0.00
PB Ratio0.91
Price to Fair Value2.00
Price to FCF27.91
Price to Operating Cash Flow8.67
PEG Ratio1.02
Income Statement
In the last 12 months, Integral Diagnostics Ltd. had revenue of 469.70M and earned -60.70M in profits. Earnings per share was -0.26.
Revenue469.70M
Gross Profit446.78M
Operating Income42.17M
Pretax Income-57.08M
Net Income-60.70M
EBITDA12.33M
Earnings Per Share (EPS)-0.26
Cash Flow
In the last 12 months, operating cash flow was 73.12M and capital expenditures -38.97M, giving a free cash flow of 34.15M billion.
Operating Cash Flow73.12M
Free Cash Flow34.15M
Free Cash Flow per Share0.09
Dividends & Yields
Integral Diagnostics Ltd. pays an annual dividend of AU$0.057, resulting in a dividend yield of 2.5%
Dividend Per ShareAU$0.057
Dividend Yield2.5%
Payout Ratio70.37%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.03
52-Week Price Change1.75%
50-Day Moving Average2.36
200-Day Moving Average2.69
Relative Strength Index (RSI)40.32
Average Volume (3m)1.26M
Important Dates
Integral Diagnostics Ltd. upcoming earnings date is Sep 1, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateSep 1, 2025
Ex-Dividend DateMar 06, 2025
Financial Position
Integral Diagnostics Ltd. as a current ratio of 0.86, with Debt / Equity ratio of 76.84%
Current Ratio0.86
Quick Ratio0.84
Debt to Market Cap0.36
Net Debt to EBITDA25.57
Interest Coverage Ratio1.89
Taxes
In the past 12 months, Integral Diagnostics Ltd. has paid 3.56M in taxes.
Income Tax3.56M
Effective Tax Rate-0.06
Enterprise Valuation
Integral Diagnostics Ltd. EV to EBITDA ratio is 74.60, with an EV/FCF ratio of 21.76.
EV to Sales1.96
EV to EBITDA74.60
EV to Free Cash Flow21.76
EV to Operating Cash Flow13.91
Balance Sheet
Integral Diagnostics Ltd. has AU$31.26M in cash and marketable securities with AU$532.65M in debt, giving a net cash position of AU$501.38M billion.
Cash & Marketable SecuritiesAU$31.26M
Total DebtAU$532.65M
Net CashAU$501.38M
Net Cash Per ShareAU$1.35
Tangible Book Value Per Share-AU$0.42
Margins
Gross margin is 26.61%, with operating margin of 8.98%, and net profit margin of -12.92%.
Gross Margin26.61%
Operating Margin8.98%
Pretax Margin-12.15%
Net Profit Margin-12.92%
EBITDA Margin2.63%
EBIT Margin-7.40%
Analyst Forecast
The average price target for Integral Diagnostics Ltd. is AU$3.55, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$3.55
Price Target Upside53.02% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast7.83%
EPS Growth Forecast―